Not currently recruiting at University of California Health
A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease
Summary
- Eligibility
- for people ages 12 years and up (full criteria)
- Location
- at UCLA
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Incyte Corporation
- ID
- NCT06388564
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 120 study participants
- Last Updated